Follow-up of Patients Operated Upon for Type II-IV Hiatal Hernia

Status Completed

Clinical Trial Summary

Surgical therapy for gastroesophageal reflux disease (GERD) and hiatal hernia (HH) can achieve outcomes that afford the patient lifelong satisfaction. The published results obtained with this surgery may not be considered to be definitive in relation to the length of follow-up or patients' life expectancy. The real recurrence rates and the results of surgery for GERD are difficult to assess due to the lack of serial time points during the follow-up. Further bias may have been introduced into the analysis by a lack of appropriate controls. The results of surgical therapy for type II-IV HH are even more controversial because of the high rate of anatomical relapse and the different methods of follow-up adopted in reported case series.

Aim of this study is to clarify the value of surgical therapy for type II-IV HH. The investigators report on patients who were followed up after surgery at various time points over the course of 30 years.

Clinical Trial Description

We reviewed the charts of patients who underwent primary surgery for type II-IV Hiatal Hernia during the period from January 1980 - December 2010.

Pre-operatively, the patients routinely underwent symptom assessment, a barium swallow, upper GI endoscopy and esophageal manometry.

The principles of surgery for GERD and hiatal hernias involve full isolation of the diaphragmatic pillars and E-G junction, full isolation and resection of the sac and fat pad into the mediastinum (except for the fat close to the lesser curvature, to preserve the integrity of the vagus nerves), evaluation of the degree of esophageal shortening, and a Collis gastroplasty in cases of short esophagi.

Post-operatively, the patients participated in a free-of-charge outpatient follow-up program at 6 months, 12 months and every year for 5 years.

The length of the follow-up was calculated from the day of the surgery to the day that the patient underwent the last complete follow-up. The type and severity of symptoms and the grade of reflux esophagitis were scored using a questionnaire with semi-quantitative scales (from 0 = absence of symptoms and esophagitis to 3 = severe symptoms and esophagitis). An evaluation scale for the surgical results, with scores ranging from "excellent" to "poor", was also used. ;

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01606449
Study type	Observational
Source	University of Bologna
Contact
Status	Completed
Phase	N/A
Start date	January 1980
Completion date	January 2012

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT00786084` - Study of Paraesophageal Hernia Repair With Small Intestine Submucosa	N/A
Recruiting	`NCT05974722` - Mesh Vs Pledgets for Repair of Paraesophageal Hernia	N/A
Recruiting	`NCT01799967` - Minimally Invasive Surgery of the Gastro-esophageal Junction
Completed	`NCT01776827` - Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital
Completed	`NCT04436159` - Partial Versus Total Fundoplication in the Surgical Repair of Para-esophageal Hernia.	N/A
Completed	`NCT04007952` - Anterior Gastropexy vs. No Anterior Gastropexy for Paraesophageal Hernia Repair	N/A
Not yet recruiting	`NCT06096402` - Gastropexy as a Treatment Option for Paraesophageal Hernia
Recruiting	`NCT06107634` - Gastropexy in the Repair of Patients With Paraesophageal Hernias	N/A
Completed	`NCT00272922` - Randomized, Prospective Controlled Trial of Paraesophageal Hernia Repair With Small Intestinal Submucosa (SIS)	N/A
Active, not recruiting	`NCT04179578` - The Value of Lateral Release in Reconstruction of the Diaphragmatic Hiatus Hernia	N/A
Recruiting	`NCT05201508` - Sutures Versus Polyglactin Mesh in Hiatal Hernia Repair	N/A
Not yet recruiting	`NCT06193551` - Ovitex in Paraesophageal and Large Hiatal Hernia Repair	N/A
Completed	`NCT01587859` - Short Esophagus in Type II-IV Hiatus Hernia	N/A
Enrolling by invitation	`NCT05807763` - Fundoplication in Laparoscopic PEH Repair Based on FLIP	N/A
Completed	`NCT03058731` - ACELL Mesh for Paraesophageal Hernia Repair
Completed	`NCT01099033` - The Biologic Basis of Hernia Formation

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.